title: Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a patient with Sézary syndrome treated by methotrexate.
authors.affiliation: Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France. saskia.oro@aphp.fr.|EA 7379 EpiDermE (Epidémiologie en Dermatologie et Evaluation des Thérapeutiques), UPEC, Créteil, France. saskia.oro@aphp.fr.
authors.forename: S
authors.initials: S
authors.lastname: Ingen-Housz-Oro
authors.affiliation: Pathology Department, AP-HP, Henri Mondor Hospital, Créteil, France.|UPEC Université Paris-Est Créteil, Créteil, France.
authors.forename: N
authors.initials: N
authors.lastname: Ortonne
authors.affiliation: Dermatology Department, CHU Pointe à Pitre, Guadeloupe, France.
authors.forename: N
authors.initials: N
authors.lastname: Cordel
authors.affiliation: Pathology Department, AP-HP, Henri Mondor Hospital, Créteil, France.
authors.forename: J
authors.initials: J
authors.lastname: Moroch
authors.affiliation: Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.|EA 7379 EpiDermE (Epidémiologie en Dermatologie et Evaluation des Thérapeutiques), UPEC, Créteil, France.
authors.forename: G
authors.initials: G
authors.lastname: Do-Pham
authors.affiliation: UPEC Université Paris-Est Créteil, Créteil, France.|Biological Immunology and Hematology Department, AP-HP, Henri Mondor Hospital, Créteil, France.
authors.forename: M H
authors.initials: MH
authors.lastname: Delfau
authors.affiliation: UPEC Université Paris-Est Créteil, Créteil, France.|Lymphoid Malignancies Unit, AP-HP, Henri Mondor Hospital, Créteil, France.
authors.forename: C
authors.initials: C
authors.lastname: Haioun
authors.affiliation: Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.|EA 7379 EpiDermE (Epidémiologie en Dermatologie et Evaluation des Thérapeutiques), UPEC, Créteil, France.|UPEC Université Paris-Est Créteil, Créteil, France.|INSERM CIC 1430, Créteil, France.
authors.forename: O
authors.initials: O
authors.lastname: Chosidow
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000150:complications* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D012751:Sezary Syndrome / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate